Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

SHE:300436 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	245.21	143.95	202.83	238.98	393.57	135.99
Cash & Short-Term Investments	245.21	143.95	202.83	238.98	393.57	135.99
Cash Growth	92.55%	-29.03%	-15.13%	-39.28%	189.41%	45.10%
Accounts Receivable	87.07	70.43	69.76	47.97	54.26	50.66
Other Receivables	1.4	28.83	25	8.21	4.94	2.02
Receivables	88.47	99.26	94.76	56.18	59.2	52.68
Inventory	143.24	114.48	111.48	68.66	81.8	52.71
Prepaid Expenses	-	-	-	-	-	0.01
Other Current Assets	76.26	49.61	40.22	30.48	15.32	16.15
Total Current Assets	553.17	407.3	449.29	394.3	549.89	257.54
Property, Plant & Equipment	550.81	588.4	639.49	584.83	509.63	420.78
Long-Term Investments	77.75	80.18	108.81	170.74	99.98	69.93
Goodwill	58.97	58.97	58.97	58.97	58.97	58.97
Other Intangible Assets	225.47	251.66	292.08	100.83	118.93	92.15
Long-Term Deferred Tax Assets	1.38	1.47	1.15	71.07	43.07	23.9
Long-Term Deferred Charges	40.96	42.78	47.75	55.22	32.56	63.96
Other Long-Term Assets	11.36	8.06	16.94	58.87	33.74	18.55
Total Assets	1,520	1,439	1,614	1,495	1,447	1,006
Accounts Payable	208.34	53.38	49.29	22.27	85.53	79.45
Accrued Expenses	11.62	174.67	175.34	89.05	38.62	37.76
Short-Term Debt	144.13	182.18	219.18	209.27	77.76	129.18
Current Portion of Long-Term Debt	111.12	117.92	72.12	17.94	62.47	-
Current Portion of Leases	-	0.1	0.18	0.19	0.11	-
Current Income Taxes Payable	10.8	2.91	1.67	3.8	3.77	3.01
Current Unearned Revenue	5.98	3.57	11.91	8.22	6.63	3.86
Other Current Liabilities	42.67	40.05	68.07	57.8	27.42	40.86
Total Current Liabilities	534.67	574.78	597.76	408.55	302.31	294.12
Long-Term Debt	180.3	142.36	167.69	84.04	47	82
Long-Term Leases	-	-	0.09	0.1	-	-
Long-Term Unearned Revenue	62.13	65.99	39.99	42.33	45.56	45.25
Long-Term Deferred Tax Liabilities	2.5	2.67	2.38	2.42	2.05	2.42
Other Long-Term Liabilities	271.78	256.24	237.31	1.79	-	-
Total Liabilities	1,051	1,042	1,045	539.22	396.92	423.79
Common Stock	159.27	159.27	159.27	159.27	158.78	140
Additional Paid-In Capital	742.37	607.93	607.93	671.32	659.29	176.43
Retained Earnings	-518.6	-407.01	-250.71	97.88	225.28	260.17
Total Common Equity	383.04	360.18	516.48	928.46	1,043	576.6
Minority Interest	85.44	36.6	52.76	27.16	6.49	5.39
Shareholders' Equity	468.48	396.78	569.24	955.62	1,050	581.99
Total Liabilities & Equity	1,520	1,439	1,614	1,495	1,447	1,006
Total Debt	435.56	442.56	459.27	311.55	187.33	211.18
Net Cash (Debt)	-190.35	-298.6	-256.44	-72.57	206.24	-75.19
Net Cash Per Share	-1.20	-1.87	-1.61	-0.46	1.38	-0.54
Filing Date Shares Outstanding	159.27	159.27	159.27	159.27	158.78	140
Total Common Shares Outstanding	159.27	159.27	159.27	159.27	158.78	140
Working Capital	18.5	-167.48	-148.48	-14.25	247.58	-36.58
Book Value Per Share	2.40	2.26	3.24	5.83	6.57	4.12
Tangible Book Value	98.6	49.56	165.44	768.66	865.45	425.48
Tangible Book Value Per Share	0.62	0.31	1.04	4.83	5.45	3.04
Buildings	-	565.95	565.02	536.94	397.03	393.34
Machinery	-	267.27	268.43	179.92	116.23	108.6
Construction In Progress	-	29.76	29.86	50.6	147.22	44.15

Source: S&P Global Market Intelligence. Standard template. Financial Sources.